Pelle Inhibitors
The protein Pelle, also known as IRAK1, plays a crucial role in Toll-like receptor (TLR) signaling pathways, particularly in orchestrating the immune response to microbial pathogens. Functioning as a serine/threonine kinase, Pelle facilitates the phosphorylation and activation of downstream effectors involved in inflammatory cytokine production and innate immune responses. Its involvement in TLR signaling underscores its significance as a mediator of host defense against infections.
Inhibition of Pelle involves diverse mechanisms aimed at dampening excessive immune responses and attenuating inflammatory signaling. Various chemical inhibitors target key signaling pathways associated with Pelle activation, including the phosphoinositide 3-kinase (PI3K)/Akt, mitogen-activated protein kinase (MAPK), and nuclear factor kappa B (NF-κB) pathways. By selectively blocking the activity of upstream kinases or modulating critical signaling molecules within these pathways, inhibitors effectively downregulate Pelle expression and activity. Additionally, compounds exert inhibitory effects on Pelle by disrupting the PI3K/Akt signaling axis, thereby attenuating downstream inflammatory responses. These findings shed light on potential strategies for modulating Pelle activity to regulate immune responses and mitigate inflammatory disorders.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Phosphoinositide 3-kinase (PI3K) inhibitor that disrupts signal transduction cascades by inhibiting PI3K activity, thereby downregulating Pelle expression. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
MEK inhibitor that blocks the mitogen-activated protein kinase (MAPK) pathway, leading to decreased Pelle activity and subsequent inhibition of downstream signaling events. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Selective inhibitor of p38 MAP kinase, which negatively regulates Pelle expression and activity by impeding the p38 MAPK signaling pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibitor of MEK1/2, upstream kinases in the MAPK/ERK pathway, resulting in the suppression of Pelle activation and downstream signaling cascades. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that blocks the PI3K/Akt pathway, leading to reduced Pelle expression and activity due to the disruption of downstream signaling pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor that targets the c-Jun N-terminal kinase (JNK) pathway, ultimately inhibiting Pelle activity by interfering with JNK-mediated signaling cascades. | ||||||
Selumetinib | 606143-52-6 | sc-364613 sc-364613A sc-364613B sc-364613C sc-364613D | 5 mg 10 mg 100 mg 500 mg 1 g | $29.00 $82.00 $420.00 $1897.00 $3021.00 | 5 | |
Selective MEK1/2 inhibitor that disrupts the MAPK/ERK pathway, resulting in the inhibition of Pelle expression and downstream signaling events. | ||||||
PD 169316 | 152121-53-4 | sc-204168 sc-204168A sc-204168B sc-204168C | 1 mg 5 mg 10 mg 25 mg | $88.00 $156.00 $281.00 $461.00 | 3 | |
Potent p38 MAP kinase inhibitor that suppresses Pelle activity by blocking the p38 MAPK signaling pathway, thereby preventing downstream effects on gene expression. | ||||||
GSK 690693 | 937174-76-0 | sc-363280 sc-363280A | 10 mg 50 mg | $255.00 $1071.00 | 4 | |
Selective inhibitor of Akt kinase, a downstream effector of PI3K, leading to decreased Pelle expression and activity through inhibition of the PI3K/Akt signaling pathway. | ||||||
Trametinib | 871700-17-3 | sc-364639 sc-364639A sc-364639B | 5 mg 10 mg 1 g | $114.00 $166.00 $947.00 | 19 | |
Highly selective inhibitor of MEK1/2, upstream regulators of the MAPK/ERK pathway, resulting in the inhibition of Pelle activation and downstream signaling cascades. | ||||||